DEFA14A: Northwest Biotherapeutics Announces Audio-Only Access Details for June 29, 2024 Annual Meeting

Northwest Biotherapeutics provides instructions for stockholders to access the Annual Meeting on June 29, 2024, via an audio-only link or telephonically, emphasizing the need to vote proxies in advance.

Summary

• Northwest Biotherapeutics has issued a supplemental disclosure regarding access to the Annual Meeting of Stockholders, scheduled for June 29, 2024, at 1:30 p.m. Eastern Time.
• Stockholders unable to attend in person can connect remotely via an audio-only link or telephonically in listening-only mode.
• The audio-only link will not enable voting during the meeting, so stockholders must vote prior to the meeting.
• The access passcode for the audio-only link is 324816.
• For telephonic access, the dial-in numbers are (669) 219-2599 or (669) 900-6833, with webinar ID 944 0129 5595 and passcode 324816.
• An informal discussion period will follow the Annual Meeting, as time permits.
• Stockholders can submit written questions to the Company before 6:00 p.m. Eastern Time on Wednesday, June 26, 2024.
• The Company encourages stockholders to vote and submit their proxies in advance, as described in the proxy materials distributed around June 3, 2024.
• Additional details are available in the definitive proxy statement filed with the SEC on June 3, 2024.

Sentiment

Score: 7

Explanation: The document is a neutral announcement regarding logistical details for the Annual Meeting, indicating a routine corporate process. The sentiment is moderately positive as it facilitates shareholder engagement.

Positives

• The company is providing multiple options (audio-only link and telephonic access) for stockholders to attend the Annual Meeting remotely.
• Stockholders have the opportunity to submit written questions in advance of the meeting.

Future Outlook

The document outlines the arrangements for the upcoming Annual Meeting, but does not provide any forward-looking statements regarding the company's financial or operational outlook.

Industry Context

This announcement is standard practice for publicly traded companies to ensure shareholder participation in important corporate governance matters.

Stakeholder Impact

• Shareholders are provided with the means to participate in the Annual Meeting.
• Shareholders are encouraged to vote on important company matters.

Next Steps

• Stockholders should vote their proxies in advance of the Annual Meeting.
• Stockholders may submit written questions to the Company prior to the deadline.
• Stockholders can attend the Annual Meeting on June 29, 2024, either in person or via the provided audio-only link or telephonically.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Northwest Biotherapeutics, Audio-Only Access, Voting